Market Insights Consumer OTC Pharmaceuticals

Sleep Aids - United States

United States

Revenue in the Sleep Aids market amounts to €1.93bn in 2024. The market is expected to grow annually by 3.39% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€1,930m in 2024).
In relation to total population figures, per person revenues of €5.65 are generated in 2024.

Key regions: Philippines, Indonesia, United Kingdom, Canada, Thailand

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Sleep Aids market in United States is experiencing significant growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in the United States are increasingly prioritizing their sleep quality and seeking solutions to improve their sleep patterns. This shift in preference is driven by the growing awareness about the importance of sleep for overall health and well-being. As a result, there is a rising demand for sleep aids that can help individuals fall asleep faster, stay asleep longer, and wake up feeling refreshed. Customers are also looking for natural and non-habit forming sleep aids, as they are more conscious about the potential side effects of medication-based solutions.

Trends in the market: One of the key trends in the Sleep Aids market in United States is the increasing popularity of sleep tracking devices and apps. These technologies allow individuals to monitor their sleep patterns, track their sleep quality, and identify factors that may be affecting their sleep. This trend is driving the demand for sleep aids that can complement these devices, such as smart pillows, sleep masks, and aromatherapy products. Another trend in the market is the growing availability of sleep aids in alternative formats. Traditionally, sleep aids were available in the form of pills or capsules. However, there is now a wider range of options, including gummies, powders, and beverages. This trend caters to customers who prefer alternative delivery formats or have difficulty swallowing pills.

Local special circumstances: The United States has a large population of individuals who suffer from sleep disorders, such as insomnia and sleep apnea. These conditions contribute to the high demand for sleep aids in the country. Additionally, the fast-paced and stressful lifestyle in many urban areas of the United States can also negatively impact sleep quality, leading individuals to seek sleep aids as a solution.

Underlying macroeconomic factors: The Sleep Aids market in United States is also influenced by underlying macroeconomic factors. The rising disposable income levels in the country have enabled more individuals to afford sleep aids and invest in their sleep quality. Additionally, the aging population in the United States is another factor driving the growth of the market. As individuals age, they are more likely to experience sleep disturbances and seek sleep aids to improve their sleep. In conclusion, the Sleep Aids market in United States is experiencing growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing awareness about the importance of sleep, the popularity of sleep tracking devices, the availability of sleep aids in alternative formats, the prevalence of sleep disorders, and the rising disposable income levels are all contributing to the development of the market in the country.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.